US 9701718
Adenovirus serotype 26 and serotype 35 filovirus vaccines
granted A61KA61K2039/5254A61K2039/5256
Quick answer
US patent 9701718 (Adenovirus serotype 26 and serotype 35 filovirus vaccines) held by THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH
- Grant date
- Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/5254, A61K2039/5256, A61K2039/70, A61K39/12